Latest filing published 14 Jun 2017 for Novelion Therapeutics Inc., €15k.
No signal scores available.
This profile gathers the share dealings of Donald Stern in Novelion Therapeutics Inc. Over a trading history stretching from 29 November 2016 to 12 June 2017, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €15k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2017 alone, the filings show 1 purchase and no sales.
The latest filing, published on 14 June 2017, reports an open-market purchase of €15k in Novelion Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations